Citation: H. Kikuchi et al., Method for evaluation of immunotoxicity of dioxin compounds using human T-lymphoblastic cell line, L-MAT, CHEMOSPHERE, 43(4-7), 2001, pp. 815-818
Authors:
Kawabata, Y
Yang, SH
Yokochi, T
Matsushita, M
Fujita, T
Shibazaki, M
Noikura, T
Endo, Y
Takada, H
Citation: Y. Kawabata et al., Complement system is involved in anaphylactoid reaction induced by lipopolysaccharides in muramyldipeptide-treated mice, SHOCK, 14(5), 2000, pp. 572-577
Authors:
Kamigiri, K
Tokunaga, T
Shibazaki, M
Setiawan, B
Rantiatmodjo, RM
Morioka, M
Suzuki, K
Citation: K. Kamigiri et al., YM-30059, a novel quinolone antibiotic produced by Arthrobacter sp. (vol 49, pg 823, 1996), J ANTIBIOT, 52(10), 1999, pp. C3-C3
Authors:
Shibazaki, M
Kawabata, Y
Yokochi, T
Nishida, A
Takada, H
Endo, Y
Citation: M. Shibazaki et al., Complement-dependent accumulation and degradation of platelets in the lungand liver induced by injection of lipopolysaccharides, INFEC IMMUN, 67(10), 1999, pp. 5186-5191
Authors:
Endo, Y
Shibazaki, M
Yamaguchi, K
Kai, K
Sugawara, S
Takada, H
Kikuchi, H
Kumagai, K
Citation: Y. Endo et al., Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment, BR J PHARM, 128(1), 1999, pp. 5-12
Authors:
Endo, Y
Shibazaki, M
Yamaguchi, K
Nakamura, M
Kosugi, H
Citation: Y. Endo et al., Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate, BR J PHARM, 126(4), 1999, pp. 903-910